教員紹介トップページへ | 三重大学トップページへ |
職名 | 教授 | |||||||||
氏名 | たなべ まさき 田辺 正樹 |
|||||||||
生年月 | 1972.08 | |||||||||
|
||||||||||
TEL | ||||||||||
FAX | ||||||||||
m-tanabe@med. (末尾に mie-u.ac.jp を補ってください) | ||||||||||
個人のホームページ | ||||||||||
学歴 | 三重大学医学部 学士課程 (~1997年)
三重大学医学部大学院博士課程 博士課程・博士後期課程 (~2005年) 卒業・修了 |
|||||||||
学位 | 博士(医学) | |||||||||
所属学会 | 日本内科学会 日本循環器学会 日本環境感染学会 日本感染症学会 日本超音波医学会 日本化学療法学会 日本公衆衛生学会 日本臨床検査医学会 | |||||||||
社会活動 | 三重県感染対策支援ネットワーク(MieICNet)事務局 | |||||||||
職歴 | 1997.05~1999.04 国立国際医療センター 内科研修医
1999.05~2000.01 三重大学医学部附属病院 第一内科 医員 2000.01~2001.06 山田赤十字病院 循環器科 医員 2001.07~2005.03 三重大学医学部附属病院 第一内科 大学院生 2005.04~2005.06 三重大学医学部附属病院 第一内科 医員 2005.07~2007.03 米国Pittsburgh大学 心エコーラボ postdoctal fellow 2007.04~2010.04 三重大学医学部附属病院 感染制御部 助教 2010.05~2011.03 三重大学医学部附属病院 医療安全・感染管理部 講師 2011.04~2012.03 厚生労働省医政局指導課 医療確保対策専門官 2012.04~2013.03 厚生労働省健康局結核感染症課 新型インフルエンザ対策推進室長補佐 2013.04~2014.06 三重大学医学部附属病院 医療安全・感染管理部 講師 2014.07~2017.03 三重大学医学部附属病院 医療安全・感染管理部 准教授 2017.04~2019.03 三重大学医学部附属病院 感染制御部 准教授 2019.04~2021.03 三重県医療保健部 医療政策総括監 2021.04~ 三重大学医学部附属病院 検査部 教授 2024.04~ 三重大学みえの未来図共創機構 感染症みらい社会教育研究センター教授 三重大学大学院医学系研究科 感染制御・感染症危機管理学 教授 三重大学医学部附属病院 感染制御部 部長 |
|||||||||
学術(芸術)賞 | ||||||||||
専門分野 | 感染制御学
感染症危機管理学 |
|||||||||
現在の研究課題 | 1. 重点感染症に対する感染症対応医薬品等(MCM)の利用可能性確保に関する研究
2. 感染症予防計画に関する研究 3. ビックデータを用いた感染症の発生動向に関する研究 4. 微生物遺伝子検査に関する研究 |
|||||||||
担当科目 | ||||||||||
主な業績等 | 1) Clinical characteristics and the risk of hospitalization of patients with coronavirus disease 2019 quarantined in a designated hotel in Japan. PLOS ONE 18(1):e020291, 2023
2) Prevalence and Clinical Characteristics of Proximal Deep Venous Thrombosis After a High-Density Coronavirus Disease 2019 Cluster in a Japanese Psychiatric Hospital. CIRC J 86:458-463, 2022 3) The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. J INFECT CHEMOTHER 28:356-358, 2022 4) Characteristics and limitations of national antimicrobial surveillance according to sales and claims data. PLOS ONE. 16:e0251299, 2021 5) An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan. J INFECT CHEMOTHER 27:972-976, 2021 6) Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance. PLOS ONE 16:e0248338, 2021 7) The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan. PLOS ONE 15:e0244521, 2020 8) Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections. BMC HEALTH SERV RES 1.110416667, 2020 9) Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data. JPN J INFECT DIS 72:326-329, 2019 10) The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. INFECTION 46:207-214, 2018 11) The Direct Comparison of Two Interferon-Gamma Release Assays for Tuberculosis Screening in Japanese Healthcare Workers. INTERNAL MED 56:773-779, 2017 12) Utility of electronic hand hygiene counting devices for measuring physicians' hand hygiene adherence applied to outpatient settings. AM J INFECT CONTROL 44:1481-1485, 2016 13) Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009-2013). J GLOB ANTIMICROB RE 7:19-23, 2016 14) Left ventricular mechanical dyssynchrony in acute onset cardiomyopathy: association of its resolution with improvements in ventricular function. JACC-CARDIOVASC IMAG 4:445-56, 2011 15) Left ventricular systolic torsion correlates global cardiac performance during dyssynchrony and cardiac resynchronization therapy.AM J PHYSIOL-HEART C 300:H853-8, 2011 16) Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. CARDIOVASC ULTRASOUN 9:31, 2011 17) Reversble left ventricular regional non-uniformity quantified by speckle-tracking displacement and strain imaging in patients with acute pulmonary embolism. J AM SOC ECHOCARDIOG 24:792-802, 2011 18) Left ventricular contraction-relaxation coupling in normal, hypertrophic, and failing myocardium quantified by speckle-tracking global strain and strain rate imaging. J AM SOC ECHOCARDIOG 23:747-54, 2010 19) Mycotic aortic aneurysm associated with Legionella anisa. J CLIN MICROBIOL 47:2340-3, 2009 20) Quantifying the role of regional dyssynchrony on global left ventricular performance. JACC-CARDIOVASC IMAG 2:1350-6, 2009 21) Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. STROKE 40:3478-84, 2009 22) Ventricular arrhythmia risk after subarachnoid hemorrhage.NEUROCRIT CARE 10:287-94, 2009 23) Molecular diagnosis of prosthetic valve endocarditis with aorto-right atrial fistula. INT J CARDIOL 135:e13-5, 2009 24) Echocardiographic speckle tracking radial strain imaging to assess ventricular dyssynchrony in a pacing model of resynchronization therapy. J AM SOC ECHOCARDIOG 21:1382-8, 2008 25) Relation of elevation in cardiac troponin I to clinical severity, cardiac dysfunction, and pulmonary congestion in patients with subarachnoid hemorrhage. AM J CARDIOL 102:1545-50, 2008 26) Hemodynamic characteristics of patients with diastolic heart failure and hypertension. HYPERTENS RES 31:1727-35, 2008 27) Impact of heart rate on mechanical dyssynchrony and left ventricular contractility in patients with heart failure and normal QRS duration. EUR J HEART FAIL 9:637-43, 2007 28) Right ventricular function following cardiac resynchronization therapy. AM J CARDIOL 100:1434-6, 2007 29) Usefulness of tissue Doppler velocity and strain dyssynchrony for predicting left ventricular reverse remodeling response after cardiac resynchronization therapy. AM J CARDIOL 100:1263-70, 2007 30) Combined longitudinal and radial dyssynchrony predicts ventricular response after resynchronization therapy. J AM COLL CARDIOL 50:1476-83, 2007 31) Differential effects of left ventricular pacing sites in an acute canine model of contraction dyssynchrony. AM J PHYSIOL-HEART C 293:H3046-55, 2007 32) Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion. J MOL CELL CARDIOL 43:130-6, 2007 33) A novel two-dimensional echocardiographic image analysis system using artificial intelligence-learned pattern recognition for rapid automated ejection fraction. J AM COLL CARDIOL 49:217-26, 2007 34) Effect of concordance between sites of left ventricular pacing and dyssynchrony on acute electrocardiographic and echocardiographic parameters in patients with heart failure undergoing cardiac resynchronization therapy. CLIN CARDIOL 29:498-502, 2006 35) Velocity vector imaging to quantify ventricular dyssynchrony and predict response to cardiac resynchronization therapy. AM J CARDIOL 98:949-53, 2006 36) Single beat determination of regional myocardial strain measurements in patients with atrial fibrillation. J AM SOC ECHOCARDIOG 19:1332-7, 2006 37) Force- and relaxation-frequency relations in patients with diastolic heart failure. AM HEART J 152:966.e1-7, 2006 38) Assessment of left ventricular systolic function in patients with chronic atrial fibrillation and dilated cardiomyopathy using the ratio of preceding to prepreceding R-R intervals. INT J CARDIOL 108:197-201, 2006 39) Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. INT J CARDIOL 104:332-7, 2005 40) Nitroglycerin improves left ventricular relaxation by changing systolic loading sequence in patients with excessive arterial load. J CARDIOVASC PHARM 45:211-6, 2005 41) Change in filling pattern with preload reduction reflects left ventricular relaxation. INT J CARDIOL 98:67-72, 2005 42) Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism. J CARDIOVASC PHARM 41:632-9, 2003 |